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Abstract
Background: Currently there is no ARDS definition or classification system that allows optimal prediction of mortality
in ARDS patients. This study aimed to examine the predictive values of the AECC and Berlin definitions, as well as
clinical and respiratory parameters obtained at onset of ARDS and in the course of the first seven consecutive days.
Methods: The observational study was conducted at a 14-bed intensive care unit specialized on treatment of ARDS.
Predictive validity of the AECC and Berlin definitions as well as PaO2/FiO2 and FiO2/PaO2*Pmean (oxygenation index) on
mortality of ARDS patients was assessed and statistically compared.
Results: Four hundred forty two critically-ill patients admitted for ARDS were analysed. Multivariate Cox regression
indicated that the oxygenation index was the most accurate parameter for mortality prediction. The third day after
ARDS criteria were met at our hospital was found to represent the best compromise between earliness and accuracy of
prognosis of mortality regarding the time of assessment. An oxygenation index of 15 or greater was associated with
higher mortality, longer length of stay in ICU and hospital and longer duration of mechanical ventilation. In addition,
non-survivors had a significantly longer length of stay and duration of mechanical ventilation in referring hospitals
before admitted to the national reference centre than survivors.
Conclusions: The oxygenation index is suggested to be the most suitable parameter to predict mortality in ARDS,
preferably assessed on day 3 after admission to a specialized centre. Patients might benefit when transferred to
specialized ICU centres as soon as possible for further treatment.
Keywords: Acute respiratory distress syndrome, Pao2/FIO2 ratio, Oxygenation index, Classification, Risk stratification,
Outcome
Background
The American-European Consensus Conference
(AECC) definition was commonly used by clinicians
to categorize ARDS patients [1]. But issues regarding
reliability of various criteria have emerged, including
a poor interobserver reliability of chest radiograph in-
terpretation, confusing acute lung injury (ALI) /ARDS
nomenclature and the inconsistency of PaO2/FiO2 ra-
tio due to the effect of positive end-expiratory
pressure (PEEP) [2]. Those limitations have recently
been tackled with the establishment of the Berlin Def-
inition in 2012 [3]. Herein, ARDS patients are classi-
fied into three independent categories (i.e., mild,
moderate and severe ARDS) and additional variables
are taken into account. Several factors, such as sever-
ity of chest radiograph, a PEEP level above 5 cm
H2O, low compliance and poor oxygenation, are now
used to define severe ARDS.
The Berlin Definition addresses and clarifies some of
the limitations of the AECC definition and is the first to
include minimum ventilator settings. The predictive val-
idity for mortality is only slightly better than in the
AECC definition. However, it was not designed to serve
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as a prognostication tool [2]. In the past, other variables
of interest, such as the PaO2/FiO2 ratio, the oxygenation
index (OI), the influence of co-morbidities and a number
of clinical scores (SAPS, SOFA), were screened in ARDS
patients to prompt early prediction of outcome and to
ensure more efficient resource allocation [4–6]. As the
ARDS is, however, a very heterogeneous syndrome with
several different causes, all proposed definitions, param-
eters and variables did not resolve the problem ad-
equately. For a reliable prediction of outcome and
mortality in ARDS patients, comparable treatment strat-
egies in respective hospitals are required. However, treat-
ment algorithms applied on ARDS patients may differ
significantly between different hospitals (usage of
inhalative nitric oxide, ventilator settings, criteria to
start lung assist devices) representing different ap-
proaches to the “state of the art” in ARDS therapy.
These problems may be partly resolved in unicentric
studies in specialized hospitals involving sufficiently
high numbers of patients.
Outcome prediction in critically ill patients at a
given point of time plays a major role (e.g. for appro-
priate treatment decisions and family communication).
In this context, we examined the predictive values of
the AECC and Berlin definition and also assessed al-
ternative clinical parameters that are available in rou-
tine patient care.
Methods
This observational analysis was conducted at a 14-bed
intensive care unit (ICU) of a national reference centre
specialized on treatment of ARDS in adult patients with
severely compromised medical conditions. On average,
two thirds of all ARDS patients are transferred from
other hospitals. Patients at our institution were treated
according to a strong treatment algorithm [7, 8].
After written consent of the Ethics Commission at
Charité - Universitätsmedizin Berlin (EA1/223/12), clin-
ical routine data from all patients admitted for ARDS
between January 2007 and December 2013 were ex-
tracted from the two electronic patient data manage-
ment systems operated at the hospital (COPRA,
Sasbachwalden, Germany and SAP, Walldorf, Germany).
In addition to basic demographic data, we assessed
length of stay and duration of prior mechanical ventila-
tion in referring institutions, comorbidities (using
Charlson comorbidity score [9]), ICU admission scores,
and use of extracorporeal oxygenation in order to
characterize the patient population. As major clinical
causes leading to ARDS, we differentiated pneumonia,
sepsis of extra-pulmonary origin, trauma, immunedefi-
ciency and “acute on chronic”, i.e. patients with an acute
pulmonary disease on pre-existing chronic pulmonary
disease (e.g.primary lung fibrosis, COPD >/= GOLD 4 or
cystic fibrosis), because these are well known influencing
factors of mortality in ARDS patients [10, 11].
Day 1 of study inclusion was defined as the first day
with a median PaO2/FiO2 below 300 at our hospital.
Patient-specific data that was extracted on a daily basis
comprised SOFA score, ventilator settings / respiratory
parameters (tidal volume (VT), tidal volume / predicted
body weight (VT/PBW), Pmean, Ppeak, PEEP, static com-
pliance, FiO2), gas exchange using arterial blood gas ana-
lyses (pH, PaO2, PaCO2, PaO2/FiO2), use of nitric oxide
and positioning therapy. Status of ARDS was assessed
according to the definition of AECC [1] and the Berlin
definition [3] upon admission on our ICU.
For analysing data based on ventilator settings and ar-
terial blood gas analyses, the following algorithm was ap-
plied: Each day was divided in four intervals of six hours
each. In each interval, the combination of ventilator
settings and results of blood gas analyses with the least
difference in time was chosen. For each of these parame-
ters, the median was calculated and transferred to the
study database. Ventilator settings had been saved ap-
proximately every 30 min in the electronic patient re-
cords and were only considered when they were
documented prior to lab results.
Predictive validity for the AECC and Berlin definition
as well as for PaO2/FiO2 and FiO2/PaO2*Pmean (OI) re-
garding mortality was assessed with receiver operator
curves (ROC) and corresponding results for area under
the curve (AUC). Kaplan-Meier curves were used to illus-
trate differences in survival using these four mentioned
parameters. In order to show differences for continuous
variables (i.e. PaO2/FiO2 and FiO2/PaO2*Pmean), we se-
lected the value that maximized the vertical distance be-
tween ROC curve and diagonal line (highest sum of
sensitivity and specificity) [12]. This cut-off value was used
to attribute patients to one of two groups (i.e. above or
below calculated cut-off) in order to analyse predictive
validity.
Descriptive analyses and statistical testing were per-
formed using the R Project of Statistical Computing
3.0.1 with a p value below 0.05 regarded as significant.
When normal distribution was ruled out using the
Kolmogorov-Smirnov test, results were given in median
and interquartile range (IQR), otherwise mean ± standard
deviation (SD). Qualitative observations were character-
ized by numbers with percentage. Statistical significance
among groups was univariately analyzed by the exact non-
parametric Kruskal-Wallis-test and (pairwise) with the
exact Mann–Whitney U test. Exact Chi-Square tests were
used for qualitative data. In order to test multivariately for
influencing factors of mortality and survival, Cox regres-
sion was applied with stepwise backwards selection in-
cluding variables that showed a statistically significant
impact in univariate analyses. All tests should be
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understood as constituting explorative analysis, such as no
adjustment for multiple testing has been made.
Results
The population analysed in this study comprised 442
critically-ill patients admitted for ARDS. As reflected by
a median APACHE II admission score of 28 [20;35], a
SAPS II admission score of 54 [39;70], a SOFA admis-
sion score of 12 [9;15] and a Charlson comorbidity index
(CCI) of 3 [2–5], the study population was characterised
by severe medical conditions (see Table 1). Along the
line, patients required in median a PEEP of 17 [15;20]
cmH2Obar, Pmean of 25 [21;29] cmH2O, and Ppeak of 36
[32;39] cmH2O on day 1 of protocol. Further respiratory
parameters are shown in Additional file 1: Table S1 in
the electronic supplement, indicating more invasive ven-
tilation in non-survivors. In 89.3 % of all patients, prone
position was applied at least once within the first three
days of protocol (see Additional file 2: Table S3 for fur-
ther details). Non-survivors were significantly older than
survivors. Also, lengths of stay in referring institutions
as well as lengths of prior mechanical ventilation were
longer in non-survivors. Although the aetiology of ARDS
was overall not statistically different between survivors
and non-survivors, the number of patients with acute on
chronic respiratory failure was higher in non-survivors;
trauma and sepsis of extrapulmonary origin were more
frequent in survivors. Scores for description of severity
of illness on ICU admission at our centre were signifi-
cantly higher in the group of non-survivors. Extracorpor-
eal lung assist devices (ELAD) including extracorporeal
membrane oxygenation (ECMO) and extracorporeal lung
assist (ECLA) were applied in 256 patients (57.9 %). When
ELAD was required in patient, it was set up within the
first three days of protocol in 87.5 % (see Additional file 3:
Table S4 for further details). Overall patient survival with
ELAD was 43.0 %.
On day 1 of the protocol, 99 patients (22.4 %) pre-
sented with a PaO2/FiO2 between 200 and 300, which
corresponds to the stage of acute lung injury (ALI)
in the AECC definition. Respectively, PaO2/FiO2 was
below 200 in the remaining 343 patients (77.6 %).
Applying the three stages of the Berlin definition,
this corresponds to 99 patients (22.4 %) with mild,
210 patients (47.5 %) with moderate and 133 patients
(30.1 %) with severe ARDS. The median for PaO2/
FiO2 (n = 411) was 137 [93;193] and 16.9 [11.6;27.4]
for OI (n = 391).
The predictive validity for in-hospital mortality of the
four parameters mentioned above – AECC definition,
Berlin definition, PaO2/ FiO2 and OI – was calculated
for the first seven days on ICU (see Fig. 1). In general,
the area under the curve was lowest for all four parame-
ters on day 1 and highest on day 7. Given that we aimed
to determine the earliest possible day for outcome pre-
diction and that all parameters showed a monotonous
increase until day 3, we decided to use clinical variables
from that day for further analyses. As extracorporeal
oxygenation was expected to have an impact on respira-
tory variables, sub-analyses were conducted regarding
the predictive value of OI in patients with ELAD, with-
out ELAD and in the entire patient population. As prog-
nostic validity was highest in the group comprising all
patients, we decided to evaluate all four categorizing
variables regardless of possible extracorporeal oxygen-
ation that might have been in place (see Additional file 4:
Figure S1).
On day 3 of protocol, 31 patients had a PaO2/
FiO2 > 300 mmHg. 32 patients died until day 3. In-
cluding data of all patients, resulting groups of all
four classifications - AECC, Berlin definition, PaO2/FiO2
and OI – based on data from day 3 were depicted as
Kaplan-Meier-curves in regards to in-hospital survival
(Fig. 2). For the continuous parameters PaO2/FiO2 and OI,
groups were identified by calculating the cut-off values
(137 for PaO2/FiO2 and 15 for OI respectively) distinguish-
ing between survival or death according to the Youden
method described above. Resulting curves in each of the
four Kaplan-Meier graphs were significantly different
(pLog rank < 0.001) from a univariate perspective. Multivari-
ate regression analyses indicated that not a singular par-
ameter may be considered for reliable mortality prediction
(see Additional file 5: Table S2). Hence, stepwise back-
wards selection allowed the identification of clinically valid
combinations of explanatory variables. In the resulting
model, OI was the only one of the four investigated cat-
egorizing variables that remained significant (HR 1.03,
95 % CI 1.015–1.047, p < 0.001). With every one-point in-
crease of OI, the risk of in-hospital death will increase by
3 %, whereas the risk of in-hospital death would increase
by 36 % if the OI increased by 10 points. Use of extracor-
poreal lung assist devices did not prove to be an inde-
pendent predictor (Table 2).
OI – being an independent predictor in the final
model of regression analysis – was then used to group
patients concerning outcome criteria. Patients with an
OI above the respective cut-off of 15 on day 3 had lon-
ger length of stay on ICU, longer length of hospital stay,
and longer duration of mechanical ventilation. Further-
more, mortality was significantly higher, with patients
less likely to be discharged to home or another facility
(see Table 3).
Discussion
In this study, we analysed early predictive values for
mortality of the AECC- and Berlin definition of ARDS,
PaO2/FiO2 and oxygenation index in critically ill ARDS
patients at the reference centre of the Charité Berlin.
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Table 1 Patient characteristics and comparison between survivors and non-survivors at diagnosis of acute respiratory distress
syndrome
All patients Survivor Non-survivor p - value
n = 442 n = 240 n = 202
Basic characteristics
Age [years] 50.0 (37.0;61.0) 46.0 (34.0;60.0) 53.0 (42.0;64.0) 0.001*
Sex (male) 285 (64.5 %) 158 (55.4 %) 127 (44.6 %) 0.602
Weight [kg] 80.0 (70.0;95.0) 83.0 (70.0;100) 80.0 (69.5;90.0) 0.001*
Body mass index [kg/m2] 28.4 (8.46) 29.6 (8.81) 26.8 (7.73) 0.001*
Transfer from other hospital 307 (69.5 %) 165 (53.7 %) 142 (46.3 %) 0.878
LOS hospital before admission [d] 7.0 (3.0;15.0) 6.0 (3.0;10.2) 11.0 (4.0;23.0) <0.001*
LOS ICU before admission [d] 4.0 (2.0;11.0) 4.0 (2.0;7.0) 6.0 (2.0;13.5) 0.002*
Duration of mechanical ventilation before admission [d] 3.0 (2.0;7.0) 3.0 (2.0;6.0) 4.0 (2.0;11.0) 0.002*
Severity of illness, organ failure and comorbidities on ICU admission
APACHE II 28.0 (20.0;35.0) 25.0 (18.0;35.2) 29.0 (24.0;37.0) <0.001*
SAPS II 54.0 (39.0;70.0) 49.0 (37.0;63.0) 61.0 (42.5;73.0) <0.001*
TISS 50.0 (43.0;58.0) 47.0 (42.0;56.0) 53.0 (45.0;59.0) <0.001*
SOFA 12.0 (9.0;15.0) 11.0 (9.0;14.0)* 13.0 (9.0;16.0)* <0.001*
CCI 3.0 (2.0–5.0)* 3.0 (2.0–5.0)* 4.0 (3.0–6.0)* <0.001*
Aetiology of ARDS 0.137
- Pneumonia 242 (54,7 %) 133 (55.0 %) 109 (45.0 %)
- Immuninsufficiency 67 (15.1 %) 30 (44.8 %) 37 (55.2 %)
- Acute on chronic 55 (12.4 %) 26 (47.3 %) 29 (52,7 %)
- Trauma 29 (6,6 %) 20 (69.0 %) 9 (31.0 %)
- Sepsis of extrapulmonary origin 27 (6.1 %) 17 (63.0 %) 10 (37.0 %)
- Other 22 (5.0 %) 14 (63.3 %) 8 (36.7 %)
Severity of lung failure (assessed on day1)
AECC Definition 0.170
ALI 99 (22.4 %) 60 (60.6 %) 39 (39.4 %)
ARDS 343 (77.6 %) 180 (52.5 %) 163 (47.5 %)
Berlin Definition 0.149
Mild 99 (22.4 %) 60 (60.6 %) 39 (39.4 %)
Moderate 210 (47.5 %) 117 (55.7 %) 93 (44.3 %)
Severe 133 (30.1 %) 63 (47.4 %) 70 (52.6 %)
PaO2/FiO2 [mmHg] 137 (92;193) 142 (95;199) 123 (89;178) 0.026*
Oxygenation index (OI) 16.9 (11.6;27.4) 16.4 (11.1;25.9) 18.5 (12.6;28.2) 0.063
Extracorporeal lung assist devices (ELAD) <0.001*
No ELAD 186 (42.1 %) 130 (69.9 %) 56 (30.1 %)
With ELAD 256 (57.9 %) 110 (43.0 %) 146 (57.0 %)
- Only ECMO 146 (33.0 %) 61 (41.8 %) 85 (58.2 %)
- Only ECLA 74 (16.7 %) 34 (46.0 %) 40 (54.0 %)
- ECLA + ECMO 36 (8.14 %) 15 (41.7 %) 21 (58.3 %)
Discrete variables are presented as number of percentage and were analysed with Chi square test for nonparametric samples. Continuous variables are presented
as median and 25/75 percentiles and were analysed with Mann–Whitney-U-Test for nonparametric samples. * p < 0,05
APACHE II Acute Physiology And Chronic Health Evaluation II, d days, ICU intensive care unit, LOS length of stay, SAPS II Simplified Acute Physiology Score II, SOFA
Sequential Organ Failure Assessment, TISS Therapeutic Intervention Scoring System, CCI Charlson comorbidity index, FiO2 inspiratory fraction of oxygen, iNO inhalative
nitric oxide, PBW predicted body weight, PaCO2 arterial partial pressure of carbon dioxide, PaO2 arterial partial pressure of oxygen, PEEP positive end-expiratory pressure,
Pmean mean airway pressure, Ppeak peak airway pressure, Vt tidal volume, ECLA extracorporeal lung assist, ECMO extracorporeal membrane oxygenation,
ELAD extracorporeal lung assist devices. Complete data on hospital stay in referring institutions was available for 309 patients
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We suggest that application of our standard operating
procedures for ARDS treatment reduced or even elimi-
nated the influence of previous, different treatment ap-
proaches. Among the four evaluated criteria to classify
or quantify severity of ARDS, OI was found to be the
most accurate parameter with respect to predictive
validity.
Regarding the time of assessment, the third day after
admission to our referral centre was found to represent
the best compromise between earliness and accuracy of
prognosis of mortality in this patient group. In the group
of patients with an OI of 15 or greater on day 3,
mortality was higher; length of stay (both in the ICU
and hospital) and duration of mechanical ventilation
were longer. Furthermore, non-survivors had a signifi-
cantly longer length of stay and duration of mechanical
Fig. 2 Survival curves for AECC and Berlin definition of acute respiratory distress syndrome, PaO2/FiO2 ratio and OI on day 3. Three hundred
seventy nine patients had a PaO2/FiO2 ratio ≤ 300 mmHg on day 3 and have been grouped in the corresponding stages of the AECC (a) and
Berlin definition (b). In total, PaO2/FiO2 was available for all 411 patients alive on day 3 (c). Values for FiO2/PaO2*Pmean were available for 391
patients being mechanically ventilated on that day (d). AECC: American-European Consensus Conference; FiO2: inspiratory fraction of oxygen; FiO2/
PaO2* Pmean describes oxygenation index. PaO2: arterial partial pressure of oxygen; Pmean: mean airway pressure, OI: oxygenation index
Fig. 1 Predicitive validity for in-hospital mortality for the first seven
days of ARDS after its diagnosis for AECC and Berlin Definition of
ARDS, paO2/FiO2, and oxygenation index. Area under ROC curve
shown for the first seven days of ARDS by 4 categorizing options of
severity of lung failure: AECC and Berlin Definition of ARDS, paO2/
FiO2 and OI
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ventilation in referring hospitals before being admitted to
the ICU than survivors of ARDS.
The OI was originally designed as a predictive tool for
pediatric patients with hypoxemic conditions [13, 14].
Later, this factor has been taken into consideration in
adults suffering from ARDS [15, 16]. Our findings re-
garding compromised outcome in patients with an OI of
15 or greater are in line with previous findings indicating
that the OI is equivalent to or even better than other
mortality prediction parameters used for ARDS, and our
study further substantiated this finding. We propose that
the OI might be one of the preferable predictive parame-
ters because it exclusively accounts for changes in mean
airway pressure and thereby reflects invasiveness of
mechanical ventilation to some extent. However, most
large observational studies on predictive parameters in
ARDS did not assess the OI to adjust the oxygenation
ration ratio to the invasiveness of ventilation or did not
report it [17, 18]. Moreover, currently used categorizing
systems, i.e. the AECC and the Berlin definition of
ARDS, do not consider the OI in their panels of defining
variables [1, 3]. To include invasiveness of ventilation, a
PEEP level of more or equal than five cm H2O became
part of the definition. In contrast, the mean PEEP level
in our study group was 17 cm H2O, which demonstrates
the severity of illness in our patient population.
In contrast to OI, the PaO2/FiO2 ratio was not an inde-
pendent predictor of mortality in our study. Although
this parameter is often used to describe oxygenation
status in critically ill patients, it also failed to predict
clinical outcome at the onset of ARDS in recent studies
[19, 20]. In this respect, our data support the concept
that the PaO2/FiO2 ratio alone might not be suitable to
determine clinical outcome in ARDS. One explanation
might be that the PaO2/FiO2 ratio is a highly variable
index depending on ventilator settings, conditions of pa-
tients and, to a more or lesser extend, routinely performed
therapeutic interventions such as bronchoscopies or posi-
tioning. FiO2 by itself, independently of PaO2/FiO2, is usu-
ally not considered to select patients regarding their risk
of poor outcome in larger clinical trails. However, it has
been shown that after controlling for baseline PaO2/FiO2,
FiO2 was able to predict mortality [21].
Villar and colleagues demonstrated that the PaO2/FiO2
ratio obtained 24 h after ARDS onset allowed a better
risk classification when FiO2 was at least 0.5 with a PEEP
of at least 10 cm H2O [22]. The OI was, however, not
part of the Villar study. A side by side comparison in
our study of the four different parameters on day 3
showed that the OI was the only parameter that was
Table 2 Multivariate Cox regression on factors influencing
hospital mortality
p - value HR 95 % CI
CCI 0.023* 1.08 1.010–1.149
OI on day 3 (per point) <0.001* 1.03 1.015–1.047
Age (per year) 0.003* 1.02 1.006–1.029
TISS28 on admission 0.006* 1.02 1.007–1.043
Crs on day 3 0.003* 0.98 0.971–0.994
Prone position on day 3 0.002* 0.81 0.711–0.928
BMI 0.097 0.98 0.956–1.004
pH on day 3 0.002* 0.03 0.002–0.275
Parameters considered in the multivariate regression model using backwards
selection that had significant impact in univariate analyses: age, BMI, Charlson
comorbidity index (CCI), ICU admission scores (APACHE II, SOFA, TISS28), ELAD
(yes/no) as well as clinical variables that were assessed on day 3 (SOFA score),
Crs Compliance of respiratory system by Crs = VT/ (Pplat - Pmean) pH day 3, Vt/
PBW, Ppeak, Prone position, categories of Berlin definition and AECC definition,
PaO2/FiO2. Data of 341 patients were considered. * p < 0,05. All parameters of
the final regression model are presented, regardless of their significance
BMI Body Mass Index, CCI Charlson comorbidity index, CI confidence interval,
ELAD extracorporeal lung assist devices (including extracorporeal lung assist
(ECLA) and extracorporeal membrane oxygenation (ECMO), FiO2 inspiratory
fraction of oxygen, HR Hazard Ratio, OI oxygenation index, PBW predicted
body weight, Ppeak peak airway pressure, TISS Therapeutic Intervention
Scoring System
Table 3 Clinical outcome parameters grouped by cut-off (15.2) of the oxygenation index FiO2/PaO2*Pmean (OI) on day 3
All patients OI day 3 < 15 OI day 3 ≥ 15 p - value
n = 442 n = 242 n = 167
Type of discharge <0.001*
- Deceased 202 (45.7 %) 71 (29.3 %) 102 (61.1 %)
- Discharged to home 60 (13.6 %) 40 (16.5 %) 17 (10.2 %)
- Transfer to another hospital 95 (21.5 %) 54 (22.3 %) 27 (16.2 %)
- Transfer to rehabilitation facility 85 (19.2 %) 59 (24.3 %) 21 (12.6 %)
LOS ICU [d] 36.0 (25.0;57.0) 33.5, (21.8;53.0) 43.0 (31.0;61.0) 0.015*
LOS hospital [d] 43.0 (27.8;66.0) 41.0 (24.0;64.0) 48.0 (34.0;72.0) 0.030*
Duration of mechanical ventilation [h] 524 (320;862) 446 (274;772) 692 (497;1007) <0.001*
Discrete variables are presented as median and percentage and were analysed with Chi square test for nonparametric samples. Continuous variables are
presented as median and 25/75 percentiles and were analysed with Mann–Whitney-U-Test for nonparametric samples. * p < 0,05
d days, h hours, ICU intensive care unit, n number, LOS length of stay, OI oxygenation index calculated as median for each day by OI = (FiO2 / PaO2[mmHg]) ×
Pmean × 100). The cut-off value was derived from Youden – Index corresponding to the area under the ROC curve for OI on day 3 for all patients
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capable of predicting mortality in multivariate analyses.
The other three, including the PaO2/FiO2 ratio, were not
identified as independent predictors.
As a known fact, PEEP was not part of the AECC
definition but was included in the Berlin definition for
classifying ARDS. More studies were conducted to verify
the predictive properties of PEEP in the definition of
ARDS after the publications of AECC and Berlin guide-
lines. Since the Berlin definition defines the minimum of
PEEP to be 5 cm H2O, many studies followed this as-
sumption and concluded differing results. As an ex-
ample, when Britos and coworkers categorized their
cases as PEEP < 5 cm H2O (1.3 %) and ≥ 10 cm H2O
(50 %), they found that after adjusting for PaO2/FiO2
baseline PEEP did not predict mortality [21]. In contrast,
in our study the median PEEP was 17 cm H2O, which
may be one of the conditions facilitating the finding of a
predictable parameter when requiring a higher PEEP.
Goligher and coworkers observed in a patient group
with a median PEEP of 9.5 cm H2O, that positive oxy-
genation response to PEEP elevation may predict mor-
tality [23]. Golighers conclusions may not be applied to
our patient population that was treated with median
PEEP of 17 cm H2O. In this regard, the use of a PEEP
level of 5 cm H2O recommended by the Berlin definition
might not be appropriate to discriminate the severity of
illness and does not allow reliable mortality prediction,
respectively. Furthermore, if a PEEP level of 5 cm H2O
would have been applied in our patient population, it is
strongly expected that the number of severe ARDS cases
would increase. Hence, the number of severe cases re-
ported in this manuscript is supposedly underestimated
from this perspective. In line with aforementioned studies,
this observation underlies the importance of standardized
conditions for ARDS classification in order to render in-
vestigations from different settings comparable.
In our study, the third day of PaO2/FiO2 < 300 mmHg
in our centre was found to represent the best comprom-
ise between earliness and accuracy of prognosis of mor-
tality in this patient group. As a special referral centre
we are sometimes unable to identify the exact onset of
ARDS, which is a limitation of our study. We suggest
that the very different treatment approaches in pre-
treating hospitals bias comparability of patients at the
time of referral to our centre. In the study by Peek and
colleagues, the different treatment procedures in hospi-
tals other than ECMO centres were considered as a
major limitation when comparing patients [24]. In our
opinion, algorithm-guided –and most importantly –
homogeneous standard treatment approaches including
ventilator settings, inhalation of nitric oxide, prone posi-
tioning or volume therapy in an ARDS centre may elim-
inate these confounding effects. In this context, our data
suggests that length of stay in hospitals before transfer
to a specialized ARDS treatment centre could impact
mortality.
Conclusions
The Berlin definition has marked a major step for a uni-
form classification of ARDS. As major finding of our
study, the OI has been proven to be a more suitable par-
ameter to predict mortality of patients suffering from
ARDS in national referral centres when compared to
PaO2/FiO2 ratio, the AECC or Berlin definition. The OI
appears to be especially helpful for prediction of mortal-
ity on day three after admission to a specialized referral
centre, as a response to standardised ARDS treatment
may be observed by that time. Secondly, early patient
transfers to specialized ARDS centres are associated with
increased survival.
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